Completed NA INTERVENTIONAL 2-arm NCT01474967

Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary Syndrome

Sponsor: Hormozgan University of Medical Sciences

Interventions Metformin

Updated 7 times since 2017 Last updated: Nov 18, 2011 Started: Feb 28, 2010 Primary completion: Jan 31, 2011 Completion: Feb 28, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01474967, this NA trial focuses on Polycystic Ovary Syndrome and remains completed. Sponsored by Hormozgan University of Medical Sciences, it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hormozgan University of Medical Sciences

Data source: Hormozgan University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bandarabbas, Iran